Sector Gamma AS
- SEC CIK
- 0001475373
- Latest filing
- Aug 12, 2026
Holdings in Q4 2024
Holdings as of Dec 31, 2024, filed Feb 11, 2025. Long positions only; changes compare share counts with Q3 2024.
- Positions
- 30
- +1 vs. Q3 2024
- Portfolio value
- $290.9M
- −$38.7M (−11.7%) vs. Q3 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PFEPfizer Inc | Stock | 1,155,000 | $30.6M | 10.5% | +335,000+40.9% | Added | History |
| MDTMedtronic plc | Stock | 320,000 | $25.6M | 8.8% | −14,890−4.4% | Reduced | History |
| BMYBristol Myers Squibb Co | Stock | 366,166 | $20.7M | 7.1% | −235,834−39.2% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 197,500 | $18.2M | 6.3% | −91,663−31.7% | Reduced | History |
| BDXBecton Dickinson & Co | Stock | 76,000 | $17.2M | 5.9% | −1,280−1.7% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 137,714 | $14.5M | 5.0% | +31,714+29.9% | Added | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 217,348 | $14.3M | 4.9% | +27,000+14.2% | Added | History |
| INCYIncyte Corp | COM | 197,400 | $13.6M | 4.7% | −61,600−23.8% | Reduced | History |
| AMGNAmgen Inc | Stock | 46,000 | $12.0M | 4.1% | +30,000+187.5% | Added | History |
| JNJJohnson & Johnson | Stock | 78,000 | $11.3M | 3.9% | +78,000 | New | History |
| CAHCardinal Health Inc | Stock | 88,000 | $10.4M | 3.6% | −29,098−24.8% | Reduced | History |
| CNCCentene Corp | Stock | 170,000 | $10.3M | 3.5% | +75,000+78.9% | Added | History |
| CVSCVS Health Corp | Stock | 217,000 | $9.74M | 3.3% | −85,000−28.1% | Reduced | History |
| BRKRBruker Corp | COM | 158,970 | $9.32M | 3.2% | 00.0% | Unchanged | History |
| QGENQiagen N.V. | Stock | 203,993 | $9.08M | 3.1% | −19,131−8.6% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 235,842 | $8.25M | 2.8% | +25,000+11.9% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 99,000 | $7.33M | 2.5% | −7,153−6.7% | Reduced | History |
| ELVElevance Health, Inc. | Stock | 17,279 | $6.37M | 2.2% | −9,000−34.2% | Reduced | History |
| BIOBio-Rad Laboratories, Inc. | CL A | 16,829 | $5.53M | 1.9% | 00.0% | Unchanged | History |
| BAXBaxter International Inc | Stock | 158,650 | $4.63M | 1.6% | −226,350−58.8% | Reduced | History |
| BNTXBioNTech SE | SPONSORED ADS | 40,000 | $4.56M | 1.6% | 00.0% | Unchanged | History |
| BIIBBiogen Inc. | COM | 29,000 | $4.43M | 1.5% | −6,166−17.5% | Reduced | History |
| GEHCGE HealthCare Technologies Inc. | Stock | 50,000 | $3.91M | 1.3% | −56,700−53.1% | Reduced | History |
| HUMHumana Inc | Stock | 14,000 | $3.55M | 1.2% | +2,000+16.7% | Added | History |
| ELANElanco Animal Health Inc | COM | 276,907 | $3.35M | 1.2% | +276,907 | New | History |
| PTCTPTC Therapeutics, Inc. | COM | 65,250 | $2.95M | 1.0% | +65,250 | New | History |
| THCTenet Healthcare Corp | COM NEW | 22,000 | $2.78M | 1.0% | −4,361−16.5% | Reduced | History |
| Tandem Diabetes Care Inc875372AB0 | NOTE 1.500% 5/0 | 66,023 | $2.38M | 0.8% | +66,023 | New | – |
| LNTHLantheus Holdings, Inc. | Stock | 25,712 | $2.30M | 0.8% | −6,000−18.9% | Reduced | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 48,495 | $1.58M | 0.5% | +9,733+25.1% | Added | History |
Sold out since Q3 2024 (3)
Positions held at the end of Q3 2024 that are gone from this filing.